Us Bancorp \De\ Adverum Biotechnologies, Inc. Transaction History

Us Bancorp \De\

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$2.08 - $3.6 $1,164 - $2,016	-560 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$3.36 - $10.56 $1,233 - $3,875	367 Added 190.16%	560 $2,000
Q2 2020 Aug 07, 2020	BUY	$8.53 - $25.64 $1,646 - $4,948	193 New	193 $4,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $424M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.